Suchergebnisse - "Yao, Hang-Ping"

PubPharm (194)

21

Duocarmycin-based antibody-drug conjugates as an emerging biotherapeutic entity for targeted cancer therapy : Pharmaceutical strategy and clinical progress

enthalten in: Drug discovery today | 2021

von Yao, H. | Zhao, H. | Hudson, R. | +2

22

RON in hepatobiliary and pancreatic cancers : Pathogenesis and potential therapeutic targets

enthalten in: World journal of gastroenterology | 2021

von Chen, S. | Wang, G. | Shi, D. | +3

23

Pharmaceutical strategies in the emerging era of antibody-based biotherapeutics for the treatment of cancers overexpressing MET receptor tyrosine kinase

enthalten in: Drug discovery today | 2021

von Yao, H. | Tong, X. | Wang, M.

24

Oncogenic mechanism-based pharmaceutical validation of therapeutics targeting MET receptor tyrosine kinase

enthalten in: Therapeutic advances in medical oncology | 2021

von Yao, H. | Tong, X. | Wang, M.

25

Novel pathogenic characteristics of highly pathogenic avian influenza virus H7N9 : viraemia and extrapulmonary infection

enthalten in: Emerging microbes & infections | 2020

von Wu, X. | Zhao, L. | Tang, S. | +11

26

Progress and challenge in development of biotherapeutics targeting MET receptor for treatment of advanced cancer

enthalten in: Biochimica et biophysica acta. Reviews on cancer | 2020

von Yao, H. | Hudson, R. | Wang, M.

27

Pathological significance of abnormal recepteur d'origine nantais and programmed death ligand 1 expression in colorectal cancer

enthalten in: World journal of gastrointestinal oncology | 2020

von Liu, Y. | Han, D. | Shi, D. | +8

28

MET and RON receptor tyrosine kinases in colorectal adenocarcinoma : molecular features as drug targets and antibody-drug conjugates for therapy

enthalten in: Journal of experimental & clinical cancer research : CR | 2020

von Yao, H. | Tong, X. | Hudson, R. | +1

29

MET and RON receptor tyrosine kinases in colorectal adenocarcinoma: molecular features as drug targets and antibody-drug conjugates for therapy

enthalten in: Journal of experimental & clinical cancer research | 2020

von Yao, H. | Tong, X. | Hudson, R. | +1

30

MET and RON receptor tyrosine kinases in colorectal adenocarcinoma: molecular features as drug targets and antibody-drug conjugates for therapy

enthalten in: Journal of experimental & clinical cancer research | 2020

von Yao, H. | Tong, X. | Hudson, R. | +1